🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Drug Safety

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites📍 Boston📍 St Louis📍 Hackensack BeOne Medicines · Tests: BG-C0979, Tislelizumab The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia NCT07186751NA2 sites📍 Beijin📍 Beijing Beijing Tiantan Hospital · Tests: Pregabalin, Pregabalin with venlafaxine An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product. NCT07629115n/a1 site📍 Seoul Innopeutics Corporation Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago · Tests: Cytalux GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites📍 New York📍 Fuzhou📍 Guangzhou Avistone Biotechnology Co., Ltd. · Tests: ANS03 A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1) NCT07823608Phase 36 sites📍 Cullman📍 Riverside📍 Bradenton Pfizer · Tests: Berobenatide, Placebo A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease NCT05837897Phase 341 sites📍 Hefei📍 Wuhu📍 Beijing Takeda · Tests: Vedolizumab IV, Placebo A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) NCT04779320Phase 396 sites📍 Phoenix📍 Los Angeles📍 San Diego Takeda · Tests: Vedolizumab IV A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors NCT05615974Phase 1, Phase 25 sites📍 Guangzhou📍 Wuhan📍 Linyi LaNova Medicines Limited · Tests: LM101, Toripalimab, Rituximab Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors NCT06598800Phase 134 sites📍 Hackensack📍 Houston📍 Fairfax BeOne Medicines · Tests: Drug: BG-T187, Other Therapeutic Agents A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration NCT06074783Phase 1, Phase 21 site📍 Nassau Cellcolabs Clinical LTD. · Tests: Human Allogeneic Bone-Marrow (BM) -Derived Mesenchymal Stromal Cells (MSCs) Product (StromaForte) JSKN022 in Subjects With Advanced Malignant Solid Tumors NCT07292402Phase 11 site📍 Guangzhou Jiangsu Alphamab Biopharmaceuticals Co., Ltd · Tests: JSKN022 Peer Support Workers Feasibility Study NCT07030192NA1 site📍 Vancouver University of British Columbia · Tests: Peer support service A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites📍 Fountain Valley📍 Jacksonville📍 Orlando Exelixis · Tests: XL309, Olaparib The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy NCT04905745n/a1 site📍 Seoul Jaseng Medical Foundation · Tests: Korean integrative medicine IKS014 in Advanced Solid Tumors That Express HER2 NCT05872295Phase 113 sites📍 Newport Beach📍 Boston📍 Nashville Iksuda Therapeutics Ltd. · Tests: IKS014 A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab NCT06145373Phase 43 sites📍 Los Angeles📍 Flowood📍 Taipei Sanofi · Tests: Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate (ATIIIC),… GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors NCT04977453Phase 1, Phase 213 sites📍 New York📍 New York📍 Huntersville GI Innovation, Inc. · Tests: GI-101, Pembrolizumab (KEYTRUDA®), Lenvatinib, GI-101A Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251Phase 1, Phase 213 sites📍 New Haven📍 Sarasota📍 Tampa Avenzo Therapeutics, Inc. · Tests: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers NCT06840119Phase 1, Phase 213 sites📍 Darlinghurst📍 Melbourne📍 Anderlecht Immunocore Ltd · Tests: IMC-R117C, Chemotherapy drug, Chemotherapy drug, Kinase inhibitor, Antiangiogenic Agent A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India NCT07685769Phase 47 sites📍 Visakhapatnam📍 Gurugram📍 Bangalore Pfizer · Tests: Rimegepant 75 mg ODT An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC NCT07482891Phase 41 site📍 Shanghai Shanghai 6th People's Hospital · Tests: Fosrolapitant and Palonosetron Hydrochloride for Injection, Dexamethasone, Olanzapine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy